Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada1.

Kohler PP, Melano RG, Patel SN, Shafinaz S, Faheem A, Coleman BL, Green K, Armstrong I, Almohri H, Borgia S, Borgundvaag E, Johnstone J, Katz K, Lam F, Muller MP, Powis J, Poutanen SM, Richardson D, Rebbapragada A, Sarabia A, Simor A, McGeer A; Toronto Invasive Bacterial Diseases Network (TIBDN).

Emerg Infect Dis. 2018 Sep;24(9):1674-1682. doi: 10.3201/eid2409.180164.

2.

Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.

Castagnola E, Tatarelli P, Mesini A, Baldelli I, La Masa D, Biassoni R, Bandettini R.

J Infect Public Health. 2019 Mar - Apr;12(2):270-274. doi: 10.1016/j.jiph.2018.11.003. Epub 2018 Nov 23.

3.

Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.

Marimuthu K, Venkatachalam I, Khong WX, Koh TH, Cherng BPZ, Van La M, De PP, Krishnan PU, Tan TY, Choon RFK, Pada SK, Lam CW, Ooi ST, Deepak RN, Smitasin N, Tan EL, Lee JJ, Kurup A, Young B, Sim NTW, Thoon KC, Fisher D, Ling ML, Peng BAS, Teo YY, Hsu LY, Lin RTP, Ong RT, Teo J, Ng OT; Carbapenemase-Producing Enterobacteriaceae in Singapore (CaPES) Study Group.

Clin Infect Dis. 2017 May 15;64(suppl_2):S68-S75. doi: 10.1093/cid/cix113.

PMID:
28475792
4.

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.

Mataseje LF, Abdesselam K, Vachon J, Mitchel R, Bryce E, Roscoe D, Boyd DA, Embree J, Katz K, Kibsey P, Simor AE, Taylor G, Turgeon N, Langley J, Gravel D, Amaratunga K, Mulvey MR.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6787-6794. doi: 10.1128/AAC.01359-16. Print 2016 Nov.

5.

Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy.

Errico G, Gagliotti C, Monaco M, Masiero L, Gaibani P, Ambretti S, Landini MP, D'Arezzo S, Di Caro A, Parisi SG, Palù G, Vespasiano F, Morsillo F, Moro ML, Procaccio F, Ricci A, Grossi PA, Pantosti A, Nanni Costa A; SInT Collaborative Study Group.

Clin Microbiol Infect. 2019 Feb;25(2):203-209. doi: 10.1016/j.cmi.2018.05.003. Epub 2018 May 22.

PMID:
29800674
6.

[Epidemic increase in the incidence of carbapenemase-producing Enterobacteriaceae in Denmark].

Wang M, Ellermann-Eriksen S, Hansen DS, Kjerulf A, Fuglsang-Damgaard D, Holm A, Østergaard C, Røder B, Sönksen UW, Detlefsen M, Hansen F, Hasman H, Hammerum A, Skov RL.

Ugeskr Laeger. 2016 Nov 7;178(45). pii: V06160422. Review. Danish.

PMID:
27855770
7.

An Irish outbreak of New Delhi metallo-β-lactamase (NDM)-1 carbapenemase-producing Enterobacteriaceae: increasing but unrecognized prevalence.

O'Connor C, Cormican M, Boo TW, McGrath E, Slevin B, O'Gorman A, Commane M, Mahony S, O'Donovan E, Powell J, Monahan R, Finnegan C, Kiernan MG, Coffey JC, Power L, O'Connell NH, Dunne CP.

J Hosp Infect. 2016 Dec;94(4):351-357. doi: 10.1016/j.jhin.2016.08.005. Epub 2016 Aug 19.

PMID:
27624807
8.

Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.

Lübbert C, Straube L, Stein C, Makarewicz O, Schubert S, Mössner J, Pletz MW, Rodloff AC.

Int J Med Microbiol. 2015 Jan;305(1):148-56. doi: 10.1016/j.ijmm.2014.12.001. Epub 2014 Dec 9.

PMID:
25547265
9.

The global epidemiology of carbapenemase-producing Enterobacteriaceae.

van Duin D, Doi Y.

Virulence. 2017 May 19;8(4):460-469. doi: 10.1080/21505594.2016.1222343. Epub 2016 Aug 11. Review.

10.

Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.

Legeay C, Thépot-Seegers V, Pailhoriès H, Hilliquin D, Zahar JR.

J Hosp Infect. 2018 Aug;99(4):390-395. doi: 10.1016/j.jhin.2018.02.003. Epub 2018 Feb 10.

PMID:
29438727
11.

Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.

Nicolas-Chanoine MH, Vigan M, Laouénan C, Robert J; “E-carb Study Group”.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):383-393. doi: 10.1007/s10096-018-3438-9. Epub 2018 Nov 28.

PMID:
30488368
12.

Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.

García-Castillo M, García-Fernández S, Gómez-Gil R, Pitart C, Oviaño M, Gracia-Ahufinger I, Díaz-Regañón J, Tato M, Cantón R; iCREST Study Group.

Int J Antimicrob Agents. 2018 Mar;51(3):511-515. doi: 10.1016/j.ijantimicag.2018.01.011. Epub 2018 Jan 31.

PMID:
29371104
13.

Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.

Legeay C, Hue R, Berton C, Cormier H, Chenouard R, Corvec S, Birgand G.

J Hosp Infect. 2019 Feb;101(2):183-187. doi: 10.1016/j.jhin.2018.10.020. Epub 2018 Oct 30.

PMID:
30389597
14.

Prevalence and Molecular Characteristics of Carbapenemase-Producing Enterobacteriaceae From Five Hospitals in Korea.

Jeong SH, Kim HS, Kim JS, Shin DH, Kim HS, Park MJ, Shin S, Hong JS, Lee SS, Song W.

Ann Lab Med. 2016 Nov;36(6):529-35. doi: 10.3343/alm.2016.36.6.529.

15.

Combined use of the modified Hodge test and carbapenemase inhibition test for detection of carbapenemase-producing Enterobacteriaceae and metallo-β-lactamase-producing Pseudomonas spp.

Song W, Hong SG, Yong D, Jeong SH, Kim HS, Kim HS, Kim JS, Bae IK.

Ann Lab Med. 2015 Mar;35(2):212-9. doi: 10.3343/alm.2015.35.2.212. Epub 2015 Feb 12.

16.

Screening of nursing home residents for colonization with carbapenem-resistant Enterobacteriaceae admitted to acute care hospitals: Incidence and risk factors.

Cunha CB, Kassakian SZ, Chan R, Tenover FC, Ziakas P, Chapin KC, Mermel LA.

Am J Infect Control. 2016 Feb;44(2):126-30. doi: 10.1016/j.ajic.2015.09.019. Epub 2015 Nov 26.

PMID:
26631643
17.

Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.

Samuelsen Ø, Overballe-Petersen S, Bjørnholt JV, Brisse S, Doumith M, Woodford N, Hopkins KL, Aasnæs B, Haldorsen B, Sundsfjord A; Norwegian Study Group on CPE.

PLoS One. 2017 Nov 15;12(11):e0187832. doi: 10.1371/journal.pone.0187832. eCollection 2017.

18.

Infection due to travel-related carbapenemase-producing Enterobacteriaceae, a largely underestimated phenomenon in Belgium.

Jans B, D Huang TD, Bauraing C, Berhin C, Bogaerts P, Deplano A, Denis O, Catry B, Glupczynski Y.

Acta Clin Belg. 2015 Jun;70(3):181-7. doi: 10.1179/2295333715Y.0000000001. Epub 2015 Mar 31.

PMID:
25825036
19.

Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.

Palacios-Baena ZR, Oteo J, Conejo C, Larrosa MN, Bou G, Fernández-Martínez M, González-López JJ, Pintado V, Martínez-Martínez L, Merino M, Pomar V, Mora-Rillo M, Rivera MA, Oliver A, Ruiz-Carrascoso G, Ruiz-Garbajosa P, Zamorano L, Bautista V, Ortega A, Morales I, Pascual Á, Campos J, Rodríguez-Baño J; GEIH-GEMARA (SEIMC) and REIPI Group for CPE.

J Infect. 2016 Feb;72(2):152-60. doi: 10.1016/j.jinf.2015.10.008. Epub 2015 Nov 4.

PMID:
26546855
20.

Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.

Velasco JM, Valderama MT, Peacock T, Warawadee N, Nogrado K, Navarro FC, Chua D Jr, Apichai S, Sirigade R, Macareo LR, Swierczewski B.

Emerg Infect Dis. 2017 Sep;23(9):1597-1598. doi: 10.3201/eid2309.161237.

Supplemental Content

Support Center